跳至主要内容
临床试验/NCT05790902
NCT05790902已完成1 期

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

Armed Forces Institute of Urology, Rawalpindi1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2022年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
142
试验地点
1
主要终点
Stone clearance rate

研究概览

简要总结

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.

详细描述

to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and quickly cures the disease thus enabling the person to return to routine activity with less adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic, unilateral, single, uncomplicated Distal Ureteric Calculi of <10 mm in size (on plain CT KUB)

排除标准

  • solitary kidney, bilateral ureteric stones, UTI, renal impairment, high-grade hydronephrosis (Grades 3 and 4), any history of previous endoscopic or surgical interventions, pregnancy, diabetes mellitus,

研究组 & 干预措施

Silodosin Group

Experimental

The patients used Silodosin for ureteric calculi

干预措施: Silodosin (Drug)

Tamsulosin Group

Experimental

The patients used Tamsulosin for ureteric calculi

干预措施: Tamsulosin (Drug)

结局指标

主要结局

Stone clearance rate

时间窗: upto 4 weeks

Stone clearance rate

次要结局

  • Stone expulsion time(upto 4 weeks)

研究者

发起方
Armed Forces Institute of Urology, Rawalpindi
申办方类型
Other
责任方
Principal Investigator
主要研究者

AJ Arif

DR ABDUL JABBAR ARIF

Armed Forces Institute of Urology, Rawalpindi

研究点 (1)

Loading locations...

相似试验